Maternal poly I:C exposure during pregnancy regulates TNFα, BDNF, and NGF expression in neonatal brain and the maternal–fetal unit of the rat

https://doi.org/10.1016/j.jneuroim.2004.10.008Get rights and content

Abstract

Maternal infection during pregnancy is associated with increased risk for neurodevelopmental disorders. Polyriboinosinic–polyribocytidilic acid (poly I:C) or saline was administered to rats to model maternal infection; levels of TNFα, brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF) were determined by ELISA. TNFα was significantly increased in maternal plasma, placenta, and amniotic fluid, while it was significantly decreased in fetal liver/spleen and neonatal brain. NGF and BDNF were significantly decreased in the placenta and fetal liver/spleen. There was no change in BDNF or NGF in the fetal or neonatal brain. Changes in TNFα, BDNF, and NGF after maternal exposure to poly I:C represent a potential mechanism through which maternal infection increases risk for neurodevelopmental disorders.

Introduction

Prenatal exposure to maternal infection is a risk factor for neurodevelopmental disorders, including schizophrenia (Brown et al., 2000), mental retardation (Rantakallio and Von Wendt, 1985), and autism (Ciaranello and Ciaranello, 1995). Little is known about the mechanism through which maternal infection acts on the developing brain to increase risk for these neurodevelopmental disorders. Because a variety of bacterial and viral maternal infections can increase risk, we have hypothesized that cytokines generated in response to infection represent a common mechanistic pathway through which early brain development is altered (Gilmore and Jarskog, 1997, Gilmore et al., 2004).

There have been several recent attempts to model the long-term consequences of maternal infection during pregnancy on behavior relevant to schizophrenia. These models include infection with human influenza virus (Shi et al., 2003), exposure to lipopolysaccharide (LPS), a bacterial cell wall endotoxin (Borrell et al., 2002, Fortier et al., 2004), and exposure to polyriboinosinic–polyribocytidilic acid (poly I:C), which mimics viral RNA (Shi et al., 2003, Zuckerman and Weiner, 2003, Zuckerman et al., 2003). These models suggest that maternally generated cytokines are likely mediators of the abnormal brain development that leads to long-term behavioral changes. In the influenza model, no virus is detected in the fetal brain (Shi et al., 2003), suggesting that the immune response to the infection plays a major role in the mechanism of action. In the poly I:C and LPS models, no infectious agent is present, implicating the cytokine response. Maternal LPS exposure does increase cytokine expression in the maternal blood, placenta, and amniotic fluid of rodents (Fidel et al., 1994, Urakubo et al., 2001, Gayle et al., 2004). There is increasing evidence of interactions between inflammatory cytokines and neurotrophins in the nervous system, and we have recently demonstrated that maternal LPS exposure also alters brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the developing brain and maternal–fetal unit (Gilmore et al., 2003). While poly I:C increases cytokine production by cells of the immune system (Kimura et al., 1994), the effect of poly I:C on cytokine or neurotrophic factor production during pregnancy is not known.

We studied the regulation of TNFα, BDNF, and NGF expression in maternal plasma, placenta, amniotic fluid, fetal liver/spleen, fetal brain, and neonatal cortex in a rodent model of maternal infection that utilizes poly I:C. We hypothesized that maternal exposure to poly I:C will regulate the expression of TNFα, BDNF, and NGF in a manner similar to that previously observed after maternal LPS exposure.

Section snippets

Animals

Experimental protocols were approved by the UNC Institutional Animal Care and Use Committee. For the acute study, gestational day 16 (E16), timed-pregnant Sprague–Dawley rats (Charles River, Raleigh, NC) were injected i.p. with poly I:C (20 mg/kg; Sigma, St. Louis. MO) or saline. The dose of 20 mg/kg was chosen, as it was the highest dose used by Shi et al. (2003). Animals were anesthetized with ether and decapitated after blood was obtained by cardiac puncture, 2, 8, and 24 h after injection.

Results

Maternal exposure to poly I:C significantly increased TNFα protein levels in the maternal plasma (treatment p=0.0031) and placenta (treatment p=0.0498), with a maximum effect at 2 h after exposure (Fig. 1; TNFα levels in the control maternal plasma were all below the level of detection). TNFα was increased in the amniotic fluid at a trend level (treatment p=0.0925). TNFα was significantly decreased in fetal liver/spleen (treatment p=0.0170). Fetal brain levels of TNFα were not changed by

Discussion

This study indicates that maternal exposure to poly I:C during pregnancy increases levels of TNFα in the maternal plasma, placenta, and amniotic fluid, suggesting that the fetus is exposed to high levels of TNFα generated by the maternal and/or placental immune system. The increases in TNFα are similar to those observed after maternal LPS exposure (Fidel et al., 1994, Urakubo et al., 2001) and indicates that maternal exposure to LPS and to poly I:C, each used to model the long-term impact of

Acknowledgements

Supported by NIMH grant MH60352 (JHG).

References (39)

  • N.P. Turrin et al.

    Pro-inflammatory and anti-inflammatory cytokine mRNA production in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide

    Brain Res. Bull.

    (2001)
  • A. Urakubo et al.

    Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain

    Schizophr. Res.

    (2001)
  • J. Xu et al.

    Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats

    Brain Res. Mol. Brain Res.

    (1998)
  • H.A. Arnett et al.

    TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

    Nat. Neurosci.

    (2001)
  • M.J. Bell et al.

    Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats

    Ped. Res.

    (2004)
  • C.D. Breder et al.

    Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system

    J. Comp. Neurol.

    (1993)
  • A.S. Brown et al.

    Maternal exposure to respiratory infections and adult schizophrenia: a prospective birth cohort study

    Schizophr. Bull.

    (2000)
  • Z. Cai et al.

    Cytokine induction in fetal brains and brain injury in neonatal rats after maternal lipopolysaccharide administration

    Pediatr. Res.

    (2000)
  • A.L. Ciaranello et al.

    The neurobiology of autism

    Annu. Rev. Neurosci.

    (1995)
  • Cited by (156)

    • Maternal immune activation in rodent models: A systematic review of neurodevelopmental changes in gene expression and epigenetic modulation in the offspring brain

      2021, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Ngf has been analysed by one group using two separate models, rat-LPS and rat-poly(I:C), (Gilmore et al., 2003, 2005) and showed no changes in expression in the fetal whole brain and juvenile cerebral cortex. By comparison, for Bdnf, results at a given timepoint and tissue appeared to correspond to model type (Fig. 7; Gilmore et al., 2003, 2005; Giovanoli et al., 2015; Hemmerle et al., 2015; Kentner et al., 2016; Lin and Wang, 2014; Money et al., 2018; Talukdar et al., 2020). Similarly, for Ntrk2, PFC expression also corresponded to immunogen used, with decreased and unchanged expression in an rat-LPS and rat-poly(I:C) model, respectively (Hemmerle et al., 2015; Kentner et al., 2016).

    View all citing articles on Scopus
    View full text